<DOC>
	<DOCNO>NCT02620670</DOCNO>
	<brief_summary>Obesity major public health problem world Mexico , addition obesity develop chronic non-communicable disease ( NCD ) type 2 diabetes mellitus ( T2DM ) cardiovascular disease ( CVD ) . So phenomenon obesity study many investigation know cause , prevention treatment . Participation body fat especially visceral area well document appearance T2DM ; however , quite interest find individual visceral obesity impair glucose tolerance , prediabetes T2DM ; present normoglycemic individual obesity . Currently , recognize physical activity influence concentration plasma glucose , promote utilization peripheral tissue , use energy source , regulation glucose transporter tissue muscle , might influence glycemic variability , therefore interest study evaluate effect physical activity moderate intensity glycemic variability individual visceral obesity normal weight without alteration tolerance glucose .</brief_summary>
	<brief_title>Evaluation Effect Moderate-intensity Physical Activity Glycemic Variability</brief_title>
	<detailed_description>A quasi-experimental longitudinal analytical study , consist two group carry : group individual visceral obesity individual normal weight ; group alteration glucose tolerance . The world work patient 30-40 year age ; group individual visceral obesity body mass index ( BMI ) 30.0-39.9 kg/m2 waist circumference great 80 cm woman 90 cm men , group individual normal weight BMI 18.5-24.9 kg/m2 low waist circumference 80 cm woman 90 cm men . It confirm curve oral glucose tolerance , individual impair glucose tolerance baseline ; likewise , determine serum level urea , creatinine , glutamic oxaloacetic transaminase ( GOT ) , glutamic pyruvic transaminase ( SGPT ) lipid level ( total cholesterol , triglyceride [ TG ] , high-density lipoprotein cholesterol [ HDL-C ] , low-density lipoprotein cholesterol [ LDL-C ] low density lipoprotein [ VLDL ] ) . BMI , waist circumference body weight distribution ( body fat percentage , visceral fat level , weight , lean body mass percentage water ) : On hand , begin end study follow determination obtain . The study last 6 day . To measure glycemic variability first day place system continuous glucose payment ( MCG ) iPro ™ 2 system ( Medtronic MiniMed , Northridge ) determine interstitial glucose level every five minute . During first 3 day individual volunteer perform usual activity , three day later make moderate intensity physical activity 30 minute morning fast 8-12 hour . From data obtain MCG mean amplitude glucose excursion ( MAGE ) , assess glycemic variability area curve ( AUC ) calculate . For statistical analysis , Mann-Whitney U test , Fisher 's exact test , Wilcoxon linear regression use . It consider significant difference p &lt; 0.05 .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>Gender : male female . Age : 3040 year . Diagnosis obesity normal weight accord WHO : Individuals normal weight BMI ≥ 18.5 24.9 kg / m2 . Individuals obesity BMI ≥ 30 39.9 kg / m2 . • Diagnosis absence visceral obesity accord WHO : Normal Weight ; waist circumference : Women &lt; 80 cm men &lt; 90 cm . • Diagnosis visceral obesity accord WHO : waist circumference : Women men ≥ 80 cm ≥ 90 cm . What sedentary past three month . Individuals committed 1530 minute physical activity exclusively least 3 time week . No change oral glucose tolerance accord ADA : fasting glucose &lt; 100 mg / dL afterload glucose &lt; 140 mg / dL . • write informed consent . Women pregnant lactating . Diagnosis DM accord ADA . Fasting glucose : ≥ 126 mg / dL glucose afterload : ≥ 140 mg / dL . Thyroid disease / hypertension . Diagnosis metabolic syndrome . Consumption oral agent medicine supplement proven property modify behavior glucose . Liver enzymes : GOT GPT concentration twice normal . Changes GFR accord Cockcroft Gault , level 60 mL / min / 1.73 m2 , suggestive chronic kidney disease . Changes serum lipid level : Total cholesterol &lt; 200 mg / dL Triglycerides &lt; 150 mg / dL HDLC &gt; 60 mg / dL LDLC &lt; 130 mg / dL</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Physical Activity</keyword>
	<keyword>Glycemic Variability</keyword>
</DOC>